• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[ABO血型系统与妇科肿瘤生存率]

[Blood groups of the ABO system and survival rate in gynecologic tumors].

作者信息

Marinaccio M, Traversa A, Carioggia E, Valentino L, Coviello M, Salamanna S, Dragone D C, Marinaccio L

机构信息

I Clinica Ginecologica e Ostetrica, Università degli Studi di Bari.

出版信息

Minerva Ginecol. 1995 Mar;47(3):69-76.

PMID:7630512
Abstract

A retrospective analysis of 968 women affected by gynecological tumors was conducted to assess the existence of a difference in survival between patients with different blood groups. Data are presented on 237 cases of endometrial cancer, 92 cases of ovarian cancer and 639 cases of invasive cervix cancer, detailing their ABO blood antigenic phenotypes, the stage of neoplasia and the treatment received. With regard to endometrial cancer, a sensibly better 5-year and 10-year survival is associated with blood group 0 if compared with blood group A. This finding is more evident when 5-year survival is considered among patients affected by ovarian cancer. With regard to cervical cancer, analysis showed that a little better than 5-year survival is associated with 0 blood phenotype; on the contrary, when a 10-year or longer survival is considered, a better survival is associated with A blood phenotype. The present study confirms evidence of an association between the A blood group and gynecological tumors. Endometrial and ovarian cancer occur more frequently in women with blood type A than in those with the other blood types, moreover, in the same tumors blood group A is associated with a poor prognosis. The possible reason for these findings are discussed with detailed regard to the possible biological importance that, at present, is conferred to the ABO group system in the complex activities of the immune system.

摘要

对968名患有妇科肿瘤的女性进行了回顾性分析,以评估不同血型患者的生存差异。呈现了237例子宫内膜癌、92例卵巢癌和639例浸润性宫颈癌的数据,详细说明了它们的ABO血型抗原表型、肿瘤分期和接受的治疗。对于子宫内膜癌,与A型血相比,0型血的5年和10年生存率明显更高。在考虑卵巢癌患者的5年生存率时,这一发现更为明显。对于宫颈癌,分析表明0型血表型的5年生存率略高;相反,当考虑10年或更长时间的生存率时,A型血表型的生存率更高。本研究证实了A型血与妇科肿瘤之间存在关联的证据。子宫内膜癌和卵巢癌在A型血女性中比在其他血型女性中更常见,此外,在相同肿瘤中,A型血与预后不良有关。针对目前ABO血型系统在免疫系统复杂活动中可能具有的生物学重要性,详细讨论了这些发现的可能原因。

相似文献

1
[Blood groups of the ABO system and survival rate in gynecologic tumors].[ABO血型系统与妇科肿瘤生存率]
Minerva Ginecol. 1995 Mar;47(3):69-76.
2
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.妇科癌症或良性妇科疾病患者术前采集血浆中的可溶性尿激酶型纤溶酶原激活物受体
Gynecol Oncol. 2001 Sep;82(3):523-31. doi: 10.1006/gyno.2001.6324.
3
Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.子宫内膜样腺癌II期:宫颈间质浸润的临床意义。
Gynecol Oncol. 2009 Jun;113(3):316-23. doi: 10.1016/j.ygyno.2009.03.007. Epub 2009 Apr 5.
4
[Prognostic factors in gynecologic cancer].[妇科癌症的预后因素]
Gan To Kagaku Ryoho. 1988 Aug;15(8):2209-15.
5
[Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].[广西壮族自治区8009例住院妇科恶性肿瘤患者的构成特征及变化趋势]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jan;42(1):22-5.
6
Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.淋巴管间隙浸润和主动脉旁阳性淋巴结组数量可预测子宫内膜癌淋巴结阳性患者的生存率。
Gynecol Oncol. 2005 Mar;96(3):651-7. doi: 10.1016/j.ygyno.2004.11.026.
7
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer.术前血小板增多是Ⅲ期和Ⅳ期子宫内膜癌的独立预后因素。
Anticancer Res. 2000 Sep-Oct;20(5C):3983-5.
8
Gynecological malignancies.妇科恶性肿瘤
Cancer Chemother Biol Response Modif. 1996;16:564-91.
9
ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.正常及恶性人子宫内膜中ABH及相关组织血型抗原与遗传和激素因素的关系
APMIS Suppl. 1997;69:1-33.
10
Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.妇科恶性肿瘤患者血液流变学、血栓形成与癌症生存之间的关联。
Clin Hemorheol Microcirc. 2000;22(2):107-30.

引用本文的文献

1
ABO/Rh Blood Group and Cervical Cancer Survival: Results from Our Own and Other Studies.ABO/Rh血型与宫颈癌生存率:来自我们自己及其他研究的结果。
J Cancer. 2024 Jul 9;15(15):4777-4788. doi: 10.7150/jca.95245. eCollection 2024.
2
Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany.ABO 血型是否为子宫内膜样子宫内膜癌患者的风险或预后因素?德国的一项回顾性分析。
Blood Transfus. 2020 Nov;18(6):465-470. doi: 10.2450/2020.002-20. Epub 2020 Jun 4.
3
The ABO Blood Group is an Independent Prognostic Factor in Patients with Ovarian Cancer.
ABO血型是卵巢癌患者的一个独立预后因素。
J Cancer. 2019 Oct 22;10(26):6754-6760. doi: 10.7150/jca.36236. eCollection 2019.
4
AB0 Blood Group and Ovarian Cancer Survival.AB0血型与卵巢癌生存率
J Cancer. 2019 Apr 25;10(9):1949-1957. doi: 10.7150/jca.29272. eCollection 2019.
5
ABO Blood Type Has No Impact on Survival in Patients with Epithelial Ovarian Cancer.ABO血型对上皮性卵巢癌患者的生存无影响。
J Cancer. 2018 Oct 21;9(23):4334-4340. doi: 10.7150/jca.27734. eCollection 2018.
6
AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer - a retrospective multi-centre study.AB0 血型和 Rh 因子表达作为上皮性卵巢癌患者的预后参数 - 一项回顾性多中心研究。
BMC Cancer. 2018 Apr 19;18(1):447. doi: 10.1186/s12885-018-4289-6.
7
ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.ABO 血型作为卵巢癌和外阴癌复发的预后因素。
PLoS One. 2018 Mar 29;13(3):e0195213. doi: 10.1371/journal.pone.0195213. eCollection 2018.
8
ABO Blood Group and Endometrial Carcinoma: A Preliminary Single-Center Experience from Saudi Arabia.ABO血型与子宫内膜癌:沙特阿拉伯单中心初步经验
Cureus. 2017 Dec 18;9(12):e1959. doi: 10.7759/cureus.1959.
9
Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies.ABO血型对I型子宫内膜癌患者的预后影响——来自我们自己及其他研究的结果
J Cancer. 2017 Aug 23;8(14):2828-2835. doi: 10.7150/jca.19524. eCollection 2017.
10
Blood type, ABO genetic variants, and ovarian cancer survival.血型、ABO基因变异与卵巢癌生存率
PLoS One. 2017 Apr 27;12(4):e0175119. doi: 10.1371/journal.pone.0175119. eCollection 2017.